Publicis Health: acquisition of BBK Worldwide
Publicis Health as acquired BBK Worldwide, a clinical trial experience specialist. The purchase is intended to complement Publicis’s existing clinical trial experience capabilities.
"BBK's powerful suite of solutions, patented technology, and category intelligence enable clients to optimize and accelerate global drug development," said Alexandra von Plato, CEO of Publicis Health. "By bringing together BBK's proprietary technology and methodologies and Langland's award-winning creative capabilities under one roof, Publicis Health creates a powerful end-to-end value proposition for our clients."
